Dr. Eckhart Weidemann is one of best non hodgkin lymphoma doctors. He heads the Hematology sector of Nordwest Clinic specializing in blood disorder treatment. The professor has over 30 years of practice.
ガル・ゴールドシュタイン博士は、ハダッサ医療センターの小児腫瘍学および血液腫瘍学の高い資格を有する経験豊富な専門家であり、2019-2020年のイスラエルのベストドクターリストにフォーブスにより選ばれ、多くのプロフェッショナル協会のメンバーです。
ルーヴェン・オア教授は、イスラエルの卓越した血液学者であり骨髄移植の専門家で、ハダッサヘブライ大学病院で15年以上の経験を持ち、2008年のメナヘム・ベギン賞を含む重要な業績を達成しています。研究のためのラボの設立、そしてハダッサ公開骨髄登録とイスラエル国立血液銀行の医療ディレクターを務めています。
Dr. Osman Ilhan is a Professor of Internal Diseases. He earned his medical degree at Ankara University in 1978. He completed his specialization in Internal Diseases there in 1982. He became an Associate Professor in 1990 and a Professor in 1996.
He served as a professor at Ankara University from 1997 to 2022. He has worked at Lokman Hekim Akay Hospital since 2023. Earlier, he held roles at MD Anderson Cancer Center (1996–1997), Ankara University (1978–1983; 1988–1995), GATA (1984–1985), and Ulus Hospital (1985–1988).
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
Dr. Polina Stepensky is an expert in saving the lives of children, performing over 3,500 bone marrow transplants and being recognized by Forbes as one of the best doctors in 2018. Here are her key takeaways:
Prof. Keun Chil Park is an oncologist who heads the Division of Hematology–Oncology at Samsung Medical Center. He earned his medical degree from the Seoul National University College of Medicine. He also participates as an active member of global cancer research and clinical societies.
Dr. Park treats patients with malignant conditions. His primary therapeutic interests include:
The doctor is a member of several domestic and international medical organizations:
Radiotherapy Specialist, Oncologist
Professor. Hematology and Transplantology Specialist
Specialist in the hematology. Specializes in the treatment of lymphomas.
Diverticular Bowel Disease (Diverticulosis)
Hydronephrosis (Kidney Swelling)
Bad Taste in Mouth
Blood in Urine (Hematuria)
Liver Abscess
Fat Metabolism Disorders
Osteomalacia (Bone Softening)
Hormone Excess
Glomerular Diseases (Nephritis, Nephrotic Syndrome)
Doctor of Medicine, Cum Laude, University of Navarra (1991)
Medical Degree, University of Navarra (1979–1985), Graduated with Honors
Board-Certified Specialist in Medical Oncology, via Spanish MIR system, Clínica Universidad de Navarra (1986–1989)
Advanced Fellowship in Immunotherapy, Cleveland Clinic Foundation, USA
Head of Medical Oncology (1993–2000) and Director of the Cancer Institute (2000–2002), General Hospital of Catalonia
Director of Hematopoietic Progenitor Transplant Program, General Hospital of Catalonia (1993–2002), accredited by the Catalonian Health Department
Senior Specialist in Oncology, Quirónsalud Torrevieja (since 2002)
Personalized Cancer Therapy using RNA microarrays and pharmacogenomics
Autologous Bone Marrow Transplants and High-Dose Chemotherapy
High-Dose Interleukin-2 Therapy via intravenous bolus for solid tumors
Personalized Cellular Anti-Tumor Vaccines
Hyperthermic Isolated Limb Perfusion with TNF and melphalan
Intra-arterial and Intraoperative Chemotherapy (HIPEC) for advanced cancers
Author of 120+ scientific papers and conference presentations
Active contributor to the development of novel cancer immunotherapies and drug personalization strategies
AACR – American Association for Cancer Research
ASCO – American Society of Clinical Oncology
ASH – American Society of Hematology
Deputy head. of the Pediatric Haematology Department